Reducing the Missed Doses of VTE Pharmacological Prophylaxis is Associated With Reduction in VTE Rate

Patil, Shekhar; Ayad, Mary; Kaushal, Shivtej; Gopal, K.; Patel, Bela

doi:10.1016/j.chest.2017.08.487

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…Also, many studies on VTE prophylaxis are limited by missed doses of enoxaparin, which may alter drug efficacy and raise VTE risk. 67 The method of VTE diagnosis in studies is also variable (routine screening vs symptom-prompted radiography), which is relevant since the clinical significance of small occult VTE is unknown.…”

Section: Antifactor Xa Monitoring and Associated Dose Adjustmentsmentioning

confidence: 99%

See 1 more Smart Citation

Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document

Rappold

Sheppard

Carmichael

et al. 2021

Trauma Surg Acute Care Open

104

View full text Add to dashboard Cite

Venous thromboembolism (VTE) is a potential sequela of injury, surgery, and critical illness. Patients in the Trauma Intensive Care Unit are at risk for this condition, prompting daily discussions during patient care rounds and routine use of mechanical and/or pharmacologic prophylaxis measures. While VTE rightfully garners much attention in clinical patient care and in the medical literature, optimal strategies for VTE prevention are still evolving. Furthermore, trauma and surgical patients often have real or perceived contraindications to prophylaxis that affect the timing of preventive measures and the consistency with which they can be applied. In this Clinical Consensus Document, the American Association for the Surgery of Trauma Critical Care Committee addresses several practical clinical questions pertaining to specific or unique aspects of VTE prophylaxis in critically ill and injured patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Antifactor Xa Monitoring and Associated Dose Adjustmentsmentioning

confidence: 99%